NCT07559825 Early-Onset Colorectal Cancer Patients Too Young for Screening
| NCT ID | NCT07559825 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Methodist Health System |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2020-01-31 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2020-01-31 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a population-based retrospective study using the Surveillance, Epidemiology, and End Results (SEER) registry and National Cancer Data Base (NCDB) to look at colorectal cancer (CRC) patients younger than 35 and comparing them against CRC patients older than 35 years of age.
Eligibility Criteria
Inclusion Criteria: * Colorectal cancer Exclusion Criteria: * No Colorectal cancer
Contact & Investigator
Rohan Jeyarajah, MD
PRINCIPAL INVESTIGATOR
Methodist Health System
Frequently Asked Questions
Who can join the NCT07559825 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07559825 currently recruiting?
Yes, NCT07559825 is actively recruiting participants. Contact the research team at ClinicalResearch@mhd.com for enrollment information.
Where is the NCT07559825 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT07559825 clinical trial?
NCT07559825 is sponsored by Methodist Health System. The principal investigator is Rohan Jeyarajah, MD at Methodist Health System. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.